{
 "context": "The following article called 'Eli Lilly Gets European Approval to Sell Trulicity, a Type 2 Diabetes Drug' was published on 2014-11-25. The body of the article is as follows:\n    \nPARIS \u2014 Eli Lilly, the American pharmaceutical giant, said on Tuesday that it had received European approval to sell its new drug for treating Type 2 diabetes, putting pressure on its Danish rival Novo Nordisk, the market leader in its category.\n\n    The day before the article was published, the stock price of Eli Lilly and Company was 56.997215270996094 and the day after the article was published, the stock price of Eli Lilly and Company was ",
 "expected": "57.329322814941406",
 "date": "2014-11-25",
 "ticker": "LLY",
 "company": "Eli Lilly and Company",
 "url": "https://www.nytimes.com/2014/11/26/business/international/eli-lilly-gets-european-approval-to-sell-trulicity-a-type-2-diabetes-drug.html"
}